- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/04
Total number of patents in this class: 26636
10-year publication summary
|
1574
|
1755
|
1840
|
2026
|
1943
|
2057
|
2145
|
2171
|
2009
|
1480
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
542 |
| Merck Patent GmbH | 5751 |
344 |
| Merck Sharp & Dohme LLC | 3734 |
324 |
| Novartis AG | 10170 |
317 |
| F. Hoffmann-La Roche AG | 7795 |
313 |
| Janssen Pharmaceutica N.V. | 3137 |
304 |
| Takeda Pharmaceutical Company Limited | 2709 |
295 |
| Hoffmann-La Roche Inc. | 3864 |
286 |
| Gilead Sciences, Inc. | 2256 |
277 |
| Incyte Corporation | 1068 |
271 |
| Boehringer Ingelheim International GmbH | 4491 |
267 |
| Amgen Inc. | 4483 |
243 |
| Genentech, Inc. | 4157 |
225 |
| Pfizer Inc. | 3423 |
211 |
| Dana-Farber Cancer Institute, Inc. | 2681 |
200 |
| AstraZeneca AB | 2831 |
174 |
| Bayer AG | 3566 |
170 |
| Bayer Pharma AG | 1002 |
160 |
| Abbvie Inc. | 1812 |
157 |
| Vertex Pharmaceuticals Incorporated | 1578 |
150 |
| Other owners | 21406 |